Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8707265 | Oral Oncology | 2018 | 9 Pages |
Abstract
The validated clinical model provided a better prognostication of risk of disease recurrence than UICC stage in the p16-negative validation cohort, and similar prognostication as the newly adopted 8th edition of the UICC staging in the p16-positive patient cohort.
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Jacob H. Rasmussen, Katrin Håkansson, Gregers B. Rasmussen, Ivan R. Vogelius, Jeppe Friborg, Barbara M. Fischer, Søren M. Bentzen, Lena Specht,